Reply

Affiliations

Comment

Alessandro Soria et al. Hepatology. 2018 Mar.

. 2018 Mar;67(3):1182-1183.

doi: 10.1002/hep.29700. Epub 2018 Jan 30.

¹ Clinic of Infectious Diseases, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.

No abstract available

Comment on

Unexpected viral relapses in hepatitis C virus-infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals.
Soria A, Fabbiani M, Lapadula G, Gori A. Soria A, et al. Hepatology. 2017 Sep;66(3):992-994. doi: 10.1002/hep.29181. Epub 2017 Jul 18. Hepatology. 2017. PMID: 28370176 No abstract available.
Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct-acting antiviral regimens matter?
Ji F, Yeo YH, Wei MT, Wei B, Dang S, Li Z, Nguyen MH. Ji F, et al. Hepatology. 2018 Mar;67(3):1180-1182. doi: 10.1002/hep.29701. Epub 2018 Jan 30. Hepatology. 2018. PMID: 29194694 No abstract available.